Search Results
83 items found for "Bryan S Yung"
- Canonical chemokine receptors as scavenging “decoys”
while maintaining the responsiveness of canonical G protein-coupled CKRs that bind to the same ligand(s) example of a dual-function receptor that directly regulates both cell migration and scavenging (Volpe S.
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Bryan Roth's work on "Built-in functional selectivity in neurons is mediated by the neuronal protein,
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
., Trumpp-Kallmeyer, S., & Humblet, C. (1998). B., Chang, B., & Peisajovich, S. G. (2017). M., & Fields, S. (2014). Deep mutational scanning: a new style of protein science.
- RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
August 2022 "Aims: The pathophysiological mechanism(s) underlying non-alcoholic fatty liver disease (
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
chronic diseases, today introduced Basecamp Bio, a wholly owned subsidiary dedicated to fueling ShouTi ’s
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
., O'Brien, S. L., Stepniewski, T. K., Selent, J., Hill, S. J., & Calebiro, D. (2023). M., Kawakami, K., Masureel, M., Maeda, S., Garcia, K. C., von Zastrow, M., Inoue, A., & Kobilka, B. Reiter, E., Ahn, S., Shukla, A.K., and Lefkowitz, R.J. (2012).
- Do You Believe AI Could Accelerate Drug Discovery?
This study examines these concerns by comparing AF2's predictions with experimental structures for docking This validates AF2's potential in enhancing drug discovery precision and efficiency.
- Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
The grant should help expand Confo Therapeutic ’s research on G protein-coupled receptor (GPCR) drug
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
However, GRK3’s functions and clinical utility in GAC progression and metastases are unknown.
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
the responsiveness of canonical G protein–coupled chemokine receptors that bind to the same ligand(s) an example of a dual-function receptor that directly regulates both cell migration and scavenging (S. Grundmann et al. 2018), did not affect chemokine scavenging, consistent with prior work (S. Scavenging may allow cells to continuously migrate by remaining responsive to chemokines (S.
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- New role of β-arrestins in MOR signaling
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5391-3. doi: 10.1073/pnas.90.12.5391. Faouzi A, Varga BR, Majumdar S. Biased Opioid Ligands. Shiraki A, Shimizu S.
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s
- Adhesion GPCR Consortium Newsletter - May 2024
I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked No wonder why Mexican cuisine has obtained the coveted status of UNESCO ́s Intangible Cultural Heritage Don’t be surprised if you find yourself singing Daddy Yankee’s “Gasolina” from the top of your lungs
- Dr. GPCR University registration is now open! Secure your spot now!
includes congrats to: Clementine E Philibert and Mikel Garcia-Marcos for their work on Smooth operator(s) challenges Modulating Vertebrate Physiology by Genomic Fine-Tuning of GPCR Functions Smooth operator(s)
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Therapy Research Structure Therapeutics Receives R&D Achievement of the Year Award for GPCR Research Bryan
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Defensins and Mrgpra2 were critical for combating S. aureus infections and the formation of neutrophil
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
December 2021 OMass Therapeutics 's founder, Carol Robinson , has been awarded the prestigious Louis-Jeantet
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. And Advance Novel Oral Small Molecule Medicines Targeting G Protein-Coupled Receptors Novo Nordisk A/S:
- VAMP2: a crucial player in the delivery of MOR to the synapse
Jurado, S., D. Goswami, Y. Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Schoch, S., F. Deak, A. K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T.
- Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
domain (WAP) is necessary for this modulatory activity, although data from GST pull-down (glutathione-S-transferase
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
These data will be shared as an oral presentation by Ron S.
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
through cAMP/protein kinase A signaling, consistent with AVPR2 coupling to the G protein subunit alpha s.
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
The results provide rationale for considering a combination(s) of FDA-approved SFK (dasatinib) and MEK
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
Further research is required to fully delineate their role(s)."
- 📰 GPCR Weekly News - January 2 to 8, 2023
s Director Stephen A.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Proc Natl Acad Sci U S A, 2020. 117(35): p. 21723-21730. 2.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Proc Natl Acad Sci U S A, 2012. 109 (45): p. 18607-12. 8.